We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Luminex and Bio-Techne Extend and Expand Partnership


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Luminex and Bio-Techne Extend and Expand Partnership"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

Luminex Corporation and Bio-Techne Corp have announced the signing of a new distribution and supply agreement through 2020. This agreement extends the relationship between the two companies for immunoassay development and commercialization of Bio-Techne biological content using the Luminex testing platform.

Furthermore the agreement allows Bio-Techne to distribute Luminex multiplexing instrumentation, including the Luminex™ 200®, FLEXMAP 3D® and the MAGPIX® platforms in major markets worldwide.

"We are very pleased to broaden our relationship with Bio-Techne, a leading global player in the research, diagnostics and clinical controls markets. We believe enabling Bio-Techne to develop assay content and distribute Luminex multiplexing instruments will aid our goal of providing laboratories of all sizes access to multiplexing solutions for a range of applications," said Todd Bennett, VP, Global Sales and Customer Operations, Luminex Corporation.

Bennett continued, "With its global scope, Bio-Techne is an ideal partner that can ensure our advanced multiplexing solutions reach the right scientists and researchers. This partnership will help accelerate science and improve the efficiency of disease-related research around the world."

"We have been a partner with Luminex for many years and given our strong market position in immunoassay applications, it is logical for Bio-Techne to continue to support our customers with complete customized workflow solutions, including instruments. This is consistent with the Company's strategic direction of providing full solutions in the Life Science research space, including both biological content and instruments," said Gerry Andros, VP of Sales for Bio-Techne Corporation.

Advertisement